Literature DB >> 2045427

Biocompatible controlled release polymers for delivery of polypeptides and growth factors.

R Langer1, M Moses.   

Abstract

The development of biocompatible, controlled release systems for macromolecules has provided the opportunity for researchers and clinicians to target and deliver, on site, biologically active factors. This advance has also facilitated the purification and characterization of a number of important biomolecules. These systems include controlled release delivery systems which release proteins through porous polymer matrices, degradable polymeric delivery systems, and modulated polymer release systems. These areas of research will be reviewed with regards to their design, release kinetics, and biocompatibilities. The utilization of these systems to release such biologically important polypeptides as growth factors (e.g., fibroblast growth factor, epidermal growth factor, transforming growth factor-B) as well as a number of important inhibitory factors (e.g., nitrosoureas, angiogenesis inhibitors) in both in vivo and in vitro studies will be discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045427     DOI: 10.1002/jcb.240450406

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

Review 1.  Growth factor delivery for tissue engineering.

Authors:  J E Babensee; L V McIntire; A G Mikos
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

2.  Fibrin gel-immobilized VEGF and bFGF efficiently stimulate angiogenesis in the AV loop model.

Authors:  Andreas Arkudas; Jimmy Tjiawi; Oliver Bleiziffer; Lucia Grabinger; Elias Polykandriotis; Justus P Beier; Michael Stürzl; Raymund E Horch; Ulrich Kneser
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

Review 3.  Physical non-viral gene delivery methods for tissue engineering.

Authors:  Adam J Mellott; M Laird Forrest; Michael S Detamore
Journal:  Ann Biomed Eng       Date:  2012-10-26       Impact factor: 3.934

4.  Controlled delivery systems for proteins using polyanhydride microspheres.

Authors:  Y Tabata; S Gutta; R Langer
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

5.  Novel factor-loaded polyphosphazene matrices: potential for driving angiogenesis.

Authors:  Olugbemisola Oredein-McCoy; Nicholas R Krogman; Arlin L Weikel; Mark D Hindenlang; Harry R Allcock; Cato T Laurencin
Journal:  J Microencapsul       Date:  2009-09       Impact factor: 3.142

6.  In situ Surface Tailoring with Zwitterionic Carboxybetaine Moieties on Self-Assembled Thin Film for Antifouling Biointerfaces.

Authors:  Chun-Jen Huang; Ying-Chih Chang
Journal:  Materials (Basel)       Date:  2013-12-27       Impact factor: 3.623

7.  Gene delivery of hypoxia-inducible VEGF targeting collagen effectively improves cardiac function after myocardial infarction.

Authors:  Jing-Bo Xia; Hai-Yan Wu; Bing-Lin Lai; Li Zheng; Deng-Cheng Zhou; Zao-Shang Chang; Cheng-Zhou Mao; Guang-Hui Liu; Kyu-Sang Park; Hui Zhao; Soo-Ki Kim; Guo-Hua Song; Dong-Qing Cai; Xu-Feng Qi
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

8.  Angiogenic Effects of Collagen/Mesoporous Nanoparticle Composite Scaffold Delivering VEGF165.

Authors:  Joong-Hyun Kim; Tae-Hyun Kim; Min Sil Kang; Hae-Won Kim
Journal:  Biomed Res Int       Date:  2016-09-05       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.